PCM
HIMS icon

Penserra Capital Management’s Hims & Hers Health HIMS Stock Holding History

Penserra Capital Management’s Portfolio HIMS Stock Details HIMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.5M Buy
101,095
+31,169
+45% +$837K 0.03% 310
2026
Q1 		$1.45M Sell
69,926
-10,873
-13% -$257K 0.02% 383
2025
Q4 		$2.62M Sell
80,799
-42,994
-35% -$1.84M 0.03% 321
2025
Q3 		$7.02M Buy
123,793
+55,552
+81% +$2.85M 0.08% 221
2025
Q2 		$3.4M Sell
68,241
-115,116
-63% -$5.2M 0.05% 285
2025
Q1 		$5.42M Sell
183,357
-104,244
-36% -$3.87M 0.1% 185
2024
Q4 		$6.95M Sell
287,601
-96,235
-25% -$2.38M 0.13% 183
2024
Q3 		$7.07M Sell
383,836
-91,424
-19% -$1.64M 0.15% 124
2024
Q2 		$9.6M Sell
475,260
-243,051
-34% -$4.04M 0.12% 161
2024
Q1 		$11.1M Buy
718,311
+162,589
+29% +$1.83M 0.14% 132
2023
Q4 		$4.95M Buy
555,722
+2,511
+0.5% +$18.6K 0.09% 157
2023
Q3 		$3.48M Buy
553,211
+219,616
+66% +$1.63M 0.07% 191
2023
Q2 		$3.13M Buy
+333,595
New +$3.31M 0.06% 239
2022
Q3 		– Sell
-5,895
Closed -$26K – 1064
2022
Q2 		$26K Buy
5,895
+785
+15% +$3.35K ﹤0.01% 1057
2022
Q1 		$27K Sell
5,110
-20
-0.4% -$99 ﹤0.01% 1170
2021
Q4 		$33K Sell
5,130
-1,869
-27% -$13.5K ﹤0.01% 1127
2021
Q3 		$52K Sell
6,999
-8,867
-56% -$75.1K ﹤0.01% 1041
2021
Q2 		$172K Buy
15,866
+10,055
+173% +$120K ﹤0.01% 673
2021
Q1 		$76K Sell
5,811
-10,448
-64% -$175K ﹤0.01% 742
2020
Q4 		$237K Buy
+16,259
New +$181K 0.01% 501

Other funds holding HIMS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
DSCM
Divisadero Street Capital Management Miami, Florida $4.41B AUM 90.53% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Penserra Capital Management's HIMS Position: Q2 2026 in Review

Penserra Capital Management increased its Hims & Hers Health (HIMS) stake by 45% in Q2 2026, buying an estimated $837K and bringing the position to 101,095 shares worth $3.5M. The position accounts for 0.03% of the portfolio, ranked #310.

Penserra Capital Management first reported a position in HIMS in Q4 2020 and has held it in 20 quarters since. The position peaked at $11.1M in Q1 2024. 506 funds tracked by Wall St. Rank hold HIMS as of Q2 2026.

  • Penserra Capital Management held 101,095 shares of Hims & Hers Health worth $3.5M as of Q2 2026.
  • Penserra Capital Management bought 31,169 Hims & Hers Health shares in Q2 2026, an estimated $837K.
  • Hims & Hers Health made up 0.03% of Penserra Capital Management's portfolio in Q2 2026, its #310 holding.
  • Penserra Capital Management first reported a position in Hims & Hers Health in Q4 2020 and has held it in 20 quarters since.
  • Penserra Capital Management's Hims & Hers Health position peaked at $11.1M in Q1 2024.
  • 506 funds tracked by Wall St. Rank held Hims & Hers Health as of Q2 2026.

Based on Penserra Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.